Ascend Wellness Holdings (AAWH) Capital Expenditures Growth (1y) (2021 - 2026)
Ascend Wellness Holdings (AAWH) Capital Expenditures Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn | 8.33% |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn | -19.86% |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | -1.95% |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 73.63% |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn | -0.19% |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | -37.60% |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn | -42.11% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Ascend Wellness Holdings | 83.23 Mn | 16.23 Mn | 45.49 Mn | -7.45% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -7.45% |
| Mar 31, 2026 | 31.21% |
| Dec 31, 2025 | -177.92% |
| Sep 30, 2025 | 1,092.05% |
| Jun 30, 2025 | 38,004.35% |
| Mar 31, 2025 | 1,538.17% |
| Dec 31, 2024 | 6,082.14% |
| Sep 30, 2024 | -45.85% |
| Jun 30, 2024 | -100.48% |
| Mar 31, 2024 | -26.52% |
| Dec 31, 2023 | -105.19% |
| Sep 30, 2023 | 268.47% |
| Jun 30, 2023 | 95,400.00% |
| Mar 31, 2023 | -7.08% |
| Dec 31, 2022 | 112.69% |
| Sep 30, 2022 | -100.96% |
| Jun 30, 2022 | 100.04% |
| Mar 31, 2022 | -98.49% |
| Dec 31, 2021 | -355.32% |
| Jun 30, 2021 | -1,152.55% |